Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
The results from a Merck-Moderna partnership validate years of research into a new approach to cancer treatment.
OpenAI's Latest Bid to Fight Anthropic: A Promise Not to Keep Customer Data
The ChatGPT maker hopes to win business customers who are upset that Anthropic is keeping their data.
Why a Payments Giant Is Paying $7 Billion for the 'Stripe of AI'
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Moderna Shares More Than Double on Success of mRNA Cancer Vaccine
Moderna Shares Double on Success of mRNA Cancer Vaccine
The results come at a pivotal moment for Moderna and mRNA research.
Carlyle Joins $1 Billion Investment Round in Missile Startup Castelion
Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in its…
Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring | Fortune
